Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | [95% CI] | p-value | HR | [95% CI] | p-value | |
Regimen | ||||||
FP (vs. F) | 0.56 | [0.39–0.82] | < 0.01 | 0.47 | [0.31–0.72] | < 0.01 |
Age | ||||||
≥65 (vs. < 65) | 0.80 | [0.55–1.17] | 0.25 | |||
Sex | ||||||
Female (vs. male) | 1.05 | [0.72–1.54] | 0.78 | |||
PS | ||||||
2–4 (vs. 0–1) | 1.22 | [0.83–1.79] | 0.32 | 0.95 | [0.62–1.48] | 0.83 |
Histology | ||||||
Intestinal (vs. diffuse) | 0.71 | [0.43–1.19] | 0.19 | 0.70 | [0.41–1.19] | 0.18 |
Unknown (vs. diffuse) | NA | NA | NA | NA | ||
Disease status | ||||||
Recurrent (vs. advanced) | 0.58 | [0.25–1.32] | 0.19 | 0.86 | [0.36–2.10] | 0.75 |
Primary site | ||||||
GEJ (vs. stomach) | 0.98 | [0.40–2.41] | 0.96 | |||
No. of metastatic sites | ||||||
≥3 (vs. 1–2) | 1.43 | [0.92–2.23] | 0.11 | 1.64 | [0.97–2.76] | 0.07 |
Target lesion | ||||||
Absence (vs. presence) | 0.95 | [0.65–1.38] | 0.78 | |||
Subtype of SPM | ||||||
Inadequate oral intake (vs. massive ascites) | 0.81 | [0.52–1.29] | 0.38 | 0.58 | [0.33–1.00] | 0.05 |
Both (vs. massive ascites) | 1.09 | [0.69–1.71] | 0.71 | 0.76 | [0.44–1.29] | 0.31 |
Serum albumin level | ||||||
< 3.1 g/ml (vs. > 3.1 g/ml) | 1.42 | [0.97–2.07] | 0.07 | 1.43 | [0.94–2.17] | 0.09 |